Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Beiyuan Hu"'
Autor:
Chuntao Wu, Beiyuan Hu, Lei Wang, Xia Wu, Haitao Gu, Hanguang Dong, Jiuliang Yan, Zihao Qi, Qi Zhang, Huan Chen, Bo Yu, Sheng Hu, Yu Qian, Shuang Dong, Qiang Li, Xu Wang, Jiang Long
Publikováno v:
iScience, Vol 26, Iss 1, Pp 105723- (2023)
Summary: Lipid metabolism is extensively reprogrammed in pancreatic ductal adenocarcinoma (PDAC). Stearoyl-coenzyme A desaturase (SCD) is a critical lipid regulator that was unexplored in PDAC. Here, we characterized the existence of cancer-associate
Externí odkaz:
https://doaj.org/article/f85056a78c374948b37c50eaa615f804
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Until now, several classification staging system and treatment algorithm for hepatocelluar carcinoma (HCC) has been presented. However, anatomical location is not taken into account in these staging systems. The aim of this study
Externí odkaz:
https://doaj.org/article/ceb5350bdc794e95b6550c864802137c
Autor:
Haoting Sun, Chaoqun Wang, Beiyuan Hu, Xiaomei Gao, Tiantian Zou, Qin Luo, Mo Chen, Yan Fu, Yuanyuan Sheng, Kaili Zhang, Yan Zheng, Xudong Ren, Shican Yan, Yan Geng, Luyu Yang, Qiongzhu Dong, Lunxiu Qin
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-12 (2021)
Abstract Intercellular cross-talk plays important roles in cancer progression and metastasis. Yet how these cancer cells interact with each other is still largely unknown. Exosomes released by tumor cells have been proved to be effective cell-to-cell
Externí odkaz:
https://doaj.org/article/88f7f0730cfe4112af899c0bf56c8dc5
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 4, Pp 937-952 (2020)
Objective: Epigenetic aberration plays an important role in the development and progression of hepatocellular carcinoma (HCC). However, the alteration of RNA N6-methyladenosine (m6A) modifications and its role in HCC progression remain unclear. We th
Externí odkaz:
https://doaj.org/article/b21222e9d76a4e12bd4d7c7e99cd2315
Autor:
Xudong Ren, Yu Zhou, Yunling Luo, Chaoqun Wang, Anna Pan, Yanqin Ju, Haoting Sun, Zhifei Lin, Beiyuan Hu, Guangzheng Sun, Wenwei Zhu, Liang Hong
Publikováno v:
Gastroenterology Research and Practice, Vol 2022 (2022)
Interleukin-6 (IL-6), an important inflammatory cytokine, is a key factor regulating cancer metastasis. Cancer cells can modulate their tumorigenic abilities by sorting specific microRNAs (miRNAs) as exosomes into the tumor microenvironment. The rela
Externí odkaz:
https://doaj.org/article/3ae4fea28f114bb4bb4cdd3f8ac2c032
Autor:
Beiyuan Hu, Tiantian Zou, Wei Qin, Xiaotian Shen, Yinghan Su, Jianhua Li, Yang Chen, Ze Zhang, Haoting Sun, Yan Zheng, Chao-Qun Wang, Zhengxin Wang, Tian-En Li, Shun Wang, Le Zhu, Xufeng Wang, Yan Fu, Xudong Ren, Qiongzhu Dong, Lun-Xiu Qin
Publikováno v:
Cancer Research. 82:3845-3857
Lenvatinib is an inhibitor of multiple receptor tyrosine kinases that was recently authorized for first-line treatment of hepatocellular carcinoma (HCC). However, the clinical benefits derived from lenvatinib are limited, highlighting the urgent need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddbf843da9415c8222bdb735202943ed
https://doi.org/10.1158/0008-5472.can-21-4140
https://doi.org/10.1158/0008-5472.can-21-4140
Autor:
Lun-Xiu Qin, Qiongzhu Dong, Xudong Ren, Yan Fu, Xufeng Wang, Le Zhu, Shun Wang, Tian-En Li, Zhengxin Wang, Chao-Qun Wang, Yan Zheng, Haoting Sun, Ze Zhang, Yang Chen, Jianhua Li, Yinghan Su, Xiaotian Shen, Wei Qin, Tiantian Zou, Beiyuan Hu
Lenvatinib is an inhibitor of multiple receptor tyrosine kinases that was recently authorized for first-line treatment of hepatocellular carcinoma (HCC). However, the clinical benefits derived from lenvatinib are limited, highlighting the urgent need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c447e6f4d25e26f09a48e9397553462c
https://doi.org/10.1158/0008-5472.c.6514100.v1
https://doi.org/10.1158/0008-5472.c.6514100.v1
Autor:
Lun-Xiu Qin, Qiongzhu Dong, Xudong Ren, Yan Fu, Xufeng Wang, Le Zhu, Shun Wang, Tian-En Li, Zhengxin Wang, Chao-Qun Wang, Yan Zheng, Haoting Sun, Ze Zhang, Yang Chen, Jianhua Li, Yinghan Su, Xiaotian Shen, Wei Qin, Tiantian Zou, Beiyuan Hu
Supplementary Data from Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff03b77db3a224b0370fdfbee69da17
https://doi.org/10.1158/0008-5472.22432256.v1
https://doi.org/10.1158/0008-5472.22432256.v1
Autor:
Midie Xu, Jiuliang Yan, Beiyuan Hu, Chuntao Wu, Haitao Gu, Zihao Qi, Tao Chen, Wenting Yang, Yan Zheng, Hanguang Dong, Weiqi Sheng, Jiang Long
Publikováno v:
Genes; Volume 13; Issue 9; Pages: 1588
Liver metastases are common in pancreatic neuroendocrine tumors (PanNETs) patients and they are considered a poor prognostic marker. This study aims to analyze the spatiotemporal patterns of genomic variations between primary and metastatic tumors, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b95a036351728e8edc8552f433ce11b2
Autor:
Chuntao Wu, Beiyuan Hu, Lei Wang, Xia Wu, Haitao Gu, Hanguang Dong, Jiuliang Yan, Zihao Qi, Qi Zhang, Huan Chen, Bo Yu, Sheng Hu, Yu Qian, Shuang Dong, Qiang Li, Xu Wang, Jiang Long
Publikováno v:
iScience. 26(1)
Lipid metabolism is extensively reprogrammed in pancreatic ductal adenocarcinoma (PDAC). Stearoyl-coenzyme A desaturase (SCD) is a critical lipid regulator that was unexplored in PDAC. Here, we characterized the existence of cancer-associated fibrobl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daef498be6a9a8cc4a04caab38c99653
https://pubmed.ncbi.nlm.nih.gov/36590169
https://pubmed.ncbi.nlm.nih.gov/36590169